CLDN18.2 expression	Gastric Cancer	CLDN18.2 expression	Gastric Cancer	EO-3021 Sensitive: B - Late Trials EO-3021 Sensitive : B	EO-3021 Sensitive: B - Late Trials EO-3021 Sensitive : B
CLDN18.2 expression	Gastroesophageal Junction Adenocarcinoma	CLDN18.2 expression	Gastroesophageal Junction Adenocarcinoma	EO-3021 Sensitive: B - Late Trials EO-3021 Sensitive : B	EO-3021 Sensitive: B - Late Trials EO-3021 Sensitive : B
CLDN18.2 expression	Esophageal Adenocarcinoma	CLDN18.2 expression	Esophageal Adenocarcinoma	zolbetuximab-clzb Sensitive: C2 – Inclusion Criteria zolbetuximab-clzb Sensitive : C2	zolbetuximab-clzb Sensitive: C2 – Inclusion Criteria zolbetuximab-clzb Sensitive : C2
CLDN18.2 expression	Gastroesophageal Junction Adenocarcinoma	CLDN18.2 expression	Gastroesophageal Junction Adenocarcinoma	zolbetuximab-clzb Sensitive: C2 – Inclusion Criteria zolbetuximab-clzb Sensitive : C2	zolbetuximab-clzb Sensitive: C2 – Inclusion Criteria zolbetuximab-clzb Sensitive : C2
CLDN18.2 expression	Gastric Adenocarcinoma	CLDN18.2 expression	Gastric Adenocarcinoma	zolbetuximab-clzb Sensitive: C2 – Inclusion Criteria zolbetuximab-clzb Sensitive : C2	zolbetuximab-clzb Sensitive: C2 – Inclusion Criteria zolbetuximab-clzb Sensitive : C2
CLDN18.2 expression	Pancreatic Cancer	CLDN18.2 expression	Pancreatic Cancer	SOT102 Sensitive: C2 – Inclusion Criteria SOT102 Sensitive : C2	SOT102 Sensitive: C2 – Inclusion Criteria SOT102 Sensitive : C2
CLDN18.2 expression	Gastric Cancer	CLDN18.2 expression	Gastric Cancer	SOT102 Sensitive: C2 – Inclusion Criteria SOT102 Sensitive : C2	SOT102 Sensitive: C2 – Inclusion Criteria SOT102 Sensitive : C2
CLDN18.2 expression	Pancreatic Cancer	CLDN18.2 expression	Pancreatic Cancer	ASP2138 Sensitive: C2 – Inclusion Criteria ASP2138 Sensitive : C2	ASP2138 Sensitive: C2 – Inclusion Criteria ASP2138 Sensitive : C2
CLDN18.2 expression	Gastric Cancer	CLDN18.2 expression	Gastric Cancer	ASP2138 Sensitive: C2 – Inclusion Criteria ASP2138 Sensitive : C2	ASP2138 Sensitive: C2 – Inclusion Criteria ASP2138 Sensitive : C2
CLDN18.2 expression	Pancreatic Cancer	CLDN18.2 expression	Pancreatic Cancer	EO-3021 Sensitive: C2 – Inclusion Criteria EO-3021 Sensitive : C2	EO-3021 Sensitive: C2 – Inclusion Criteria EO-3021 Sensitive : C2
CLDN18.2 expression	Solid Tumor	CLDN18.2 expression	Solid Tumor	EO-3021 Sensitive: C2 – Inclusion Criteria EO-3021 Sensitive : C2	EO-3021 Sensitive: C2 – Inclusion Criteria EO-3021 Sensitive : C2
CLDN18.2 expression	Lung Cancer	CLDN18.2 expression	Lung Cancer	EO-3021 Sensitive: C2 – Inclusion Criteria EO-3021 Sensitive : C2	EO-3021 Sensitive: C2 – Inclusion Criteria EO-3021 Sensitive : C2

CLDN18.2 expression

Associations